Teriparatide and its Bone Healing Power

Authors

Aneeta J. Joseph, HCA HealthcareFollow
Jesus L. Penabad, HCA HealthcareFollow
Antonio Pinero-Pilona, HCA HealthcareFollow

Files

Division

West Florida

Hospital

Regional Medical Center Bayonet Point

Specialty

Endocrinology

Document Type

Poster

Publication Date

5-2020

Keywords

Osteoporosis; Fracture; Teriparatide; Healing

Disciplines

Endocrinology, Diabetes, and Metabolism | Musculoskeletal Diseases | Nutritional and Metabolic Diseases | Rheumatology

Abstract

Teriparatide, a parathyroid hormone analog, is an important anabolic agent approved by the U.S. Food and Drug Administration to increase bone mineral density in osteoporotic patients. Parathyroid hormone (PTH) regulates calcium, phosphate, and active vitamin-D metabolites. The amino terminal peptide fragments of PTH has been known to increase bone mass and are being used in clinical practice for osteoporosis management.3 Teriparatide increases bone density of lumbar spine and femoral neck, and decreases the risk of vertebral and non-vertebral fractures both in postmenopausal women and men. It is also known to prevent fractures in patients with osteoporosis and promote healing of fractures.

Recommended Citation

Joseph, Aneeta J.; Penabad, Jesus L.; and Pinero-Pilona, Antonio, "Teriparatide and its Bone Healing Power" (2020). West Florida Division GME Research Day 2020. 16.
https://scholarlycommons.hcahealthcare.com/westflorida2020/16